A detailed history of Hrt Financial LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Hrt Financial LP holds 30,658 shares of VNDA stock, worth $161,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,658
Previous 61,922 50.49%
Holding current value
$161,567
Previous $261,000 51.72%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$3.47 - $4.61 $108,486 - $144,127
-31,264 Reduced 50.49%
30,658 $126,000
Q4 2023

Feb 09, 2024

SELL
$3.38 - $4.58 $749,961 - $1.02 Million
-221,882 Reduced 78.18%
61,922 $261,000
Q3 2023

Nov 13, 2023

BUY
$4.28 - $6.57 $1.21 Million - $1.86 Million
283,804 New
283,804 $1.23 Million
Q4 2022

Feb 10, 2023

SELL
$6.87 - $10.96 $523,205 - $834,691
-76,158 Reduced 58.68%
53,627 $396,000
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $676,772 - $843,097
71,692 Added 123.41%
129,785 $1.28 Million
Q2 2022

Aug 12, 2022

BUY
$9.31 - $11.84 $540,845 - $687,821
58,093 New
58,093 $633,000
Q1 2022

May 16, 2022

SELL
$10.84 - $16.55 $265,038 - $404,647
-24,450 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$15.69 - $21.14 $383,620 - $516,873
24,450 New
24,450 $383,000
Q3 2021

Nov 15, 2021

SELL
$15.35 - $21.27 $269,714 - $373,735
-17,571 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$15.71 - $21.51 $198,810 - $272,209
-12,655 Reduced 41.87%
17,571 $377,000
Q1 2021

May 17, 2021

BUY
$13.42 - $20.28 $405,632 - $612,983
30,226 New
30,226 $453,000
Q4 2020

Feb 16, 2021

SELL
$9.77 - $13.81 $110,195 - $155,762
-11,279 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$9.32 - $12.02 $158,467 - $204,376
-17,003 Reduced 60.12%
11,279 $108,000
Q2 2020

Aug 14, 2020

BUY
$9.66 - $12.02 $273,204 - $339,949
28,282 New
28,282 $323,000
Q1 2020

May 15, 2020

SELL
$7.5 - $16.8 $113,805 - $254,923
-15,174 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$12.38 - $17.47 $187,854 - $265,089
15,174 New
15,174 $249,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $298M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.